Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner by Avadhanula, Vasanthi et al.
JOURNAL OF VIROLOGY, Feb. 2006, p. 1629–1636 Vol. 80, No. 4
0022-538X/06/$08.000 doi:10.1128/JVI.80.4.1629–1636.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Respiratory Viruses Augment the Adhesion of Bacterial Pathogens to
Respiratory Epithelium in a Viral Species- and Cell
Type-Dependent Manner
Vasanthi Avadhanula,1,2 Carina A. Rodriguez,1† John P. DeVincenzo,3,4 Yan Wang,1
Richard J. Webby,1 Glen C. Ulett,1‡ and Elisabeth E. Adderson1,2,3*
Department of Infectious Diseases, St. Jude Children’s Research Hospital,1 Departments of Molecular Sciences2 and
Pediatrics,3 University of Tennessee, Memphis, and Children’s Foundation Research Center,
LeBonheur Children’s Medical Center,4 Memphis, Tennessee
Received 7 September 2005/Accepted 1 December 2005
Secondary bacterial infections often complicate respiratory viral infections, but the mechanisms whereby
viruses predispose to bacterial disease are not completely understood. We determined the effects of infection
with respiratory syncytial virus (RSV), human parainfluenza virus 3 (HPIV-3), and influenza virus on the
abilities of nontypeable Haemophilus influenzae and Streptococcus pneumoniae to adhere to respiratory epithelial
cells and how these viruses alter the expression of known receptors for these bacteria. All viruses enhanced
bacterial adhesion to primary and immortalized cell lines. RSV and HPIV-3 infection increased the expression
of several known receptors for pathogenic bacteria by primary bronchial epithelial cells and A549 cells but not
by primary small airway epithelial cells. Influenza virus infection did not alter receptor expression. Paramyxo-
viruses augmented bacterial adherence to primary bronchial epithelial cells and immortalized cell lines by
up-regulating eukaryotic cell receptors for these pathogens, whereas this mechanism was less significant in
primary small airway epithelial cells and in influenza virus infections. Respiratory viruses promote bacterial
adhesion to respiratory epithelial cells, a process that may increase bacterial colonization and contribute to
disease. These studies highlight the distinct responses of different cell types to viral infection and the need to
consider this variation when interpreting studies of the interactions between respiratory cells and viral
pathogens.
Respiratory infections are a leading cause of morbidity and
mortality, but our understanding of their pathogenesis remains
incomplete. Recent studies have drawn attention to the role
that viral infections may play in predisposing persons to bac-
terial respiratory infections. There is considerable epidemio-
logic evidence that viral respiratory infections, particularly
those caused by influenza virus and respiratory syncytial virus
(RSV), increase the incidence and severity of severe secondary
bacterial complications, such as pneumonia and sepsis (6, 18,
20, 33). Reducing the number of viral infections by immuniza-
tion reduces the incidence of bacterial infections, supporting
this concept (4, 35).
Viral infections might predispose to bacterial secondary in-
fections by damaging respiratory epithelium, impairing muco-
ciliary function, and triggering host inflammatory responses
(26, 43). The most common bacterial respiratory pathogens,
nontypeable Haemophilus influenzae (NTHi) and Streptococcus
pneumoniae, are isolated more frequently and in larger num-
bers from the sputum of patients with viral infections than
from those without these infections, suggesting a link exists
between viral infection and bacterial colonization (36, 42).
Jiang and colleagues noted that RSV infection of A549 respi-
ratory epithelial cells significantly increased numbers of NTHi
bacteria adhering to these cells, providing experimental sup-
port for this hypothesis (17). Influenza A virus and rhinovirus
infection of tracheal epithelial cells similarly increased the
number of adherent S. pneumoniae, indicating that the ability
to augment bacterial adherence to host cells may be a general
feature of respiratory viruses (16, 31).
NTHi adheres to a diverse group of host cell molecules on
the respiratory epithelium. Phosphorylcholine residues present
on NTHi lipoligosaccharide interact with PAF-r (37), P5 fim-
briae specifically bind to host CEACAM1 (15) and ICAM-1
(2a), and sialic acid-containing oligosaccharides bind to respi-
ratory epithelial mucin (32). Mucin also plays an important
role in the adherence of NTHi. Pneumococcal cell wall phos-
phorylcholine also mediates bacterial adherence to lung epi-
thelial cells via PAF-r (8). To clarify how viral infection mod-
ulates the adhesion of bacterial pathogens to respiratory
epithelium, we determined how infection with the ubiquitous
human respiratory viruses RSV, human parainfluenza virus 3
(HPIV-3), and influenza virus altered NTHi and pneumococ-
cal adhesion to immortalized and primary respiratory cells and
the expression of known epithelial receptors for these bacteria.
Each of these viruses increased bacterial adhesion to respira-
tory epithelial cells. The mechanisms by which viruses pro-
moted bacterial colonization, however, varied between respi-
ratory pathogens and were cell type dependent. These studies
also demonstrated that different respiratory epithelial cells
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have distinct responses to infection by the same virus. These
differences must be considered when extrapolating results of in
vitro assays to human disease.
MATERIALS AND METHODS
Epithelial cell culture. A549 cells (American Type Culture Collection
[ATCC], Manassas, VA) were grown in Hams F-12K medium (ATCC) with 10%
heat-inactivated fetal bovine serum (Cambrex Corporation, East Rutherford,
NJ). BEAS-2B human bronchial epithelial cells (ATCC) were propagated in
flasks coated with 0.01 mg/ml fibronectin (Sigma, St. Louis, MO), 0.03 mg/ml
collagen (Vitrogen 100; Collagen Corporation, Palo Alto, CA), and 0.01 mg/ml
bovine serum albumin (BD Biosciences, San Jose, CA) in supplemented bron-
chial epithelial growth medium (Cambrex). Primary normal human small airway
(SAE) and primary human bronchial epithelial (NHBE) cells (Cambrex) were
maintained in supplemented serum-free medium (Cambrex) and used at the
fourth passage.
Virus and bacterial strains. RSV (A2) Long strain stocks were prepared as
described previously (19). Influenza virus strain A/Panama/2007/99 (H3N2) and
HPIV-3 were obtained from the viral repository of St. Jude Children’s Research
Hospital. For NTHi, most assays were performed with NTHi strain 778, a clinical
isolate obtained from both blood and respiratory tract cultures of an infant with
pneumonia (29). This isolate expresses the Hap and high-molecular-weight 1 and
2 (HMW1/HMW2) adhesins, pili (Hif), P5 fimbriae, and phosphorylcholine
(data not shown). Other NTHi strains tested included wild-type strains 781
(hap hmw; lacking hia and hif), 786 (hap hia; lacking hmw and hif), and 801
(hap hif; lacking hmw and hia), Rd, and the encapsulated serotype B strain
Eagan. NTHi was propagated in brain heart infusion broth (Difco, Sparks, MD)
with 10 g/ml hemin (Sigma) and 1 g/ml of -NAD (Sigma) at 37°C in 5% CO2.
S. pneumoniae strain 357 (provided by E. Tuomanen, St. Jude Children’s Re-
search Hospital) is a serotype 19 nasopharyngeal isolate that expresses phospho-
rylcholine. It was propagated in CY medium at 30°C with 5% CO2 (21).
Bacteria were grown overnight in liquid broth, diluted 1:10 in fresh medium, and
grown to log phase. Prior to assays, bacteria were washed three times in phos-
phate-buffered saline (PBS) and diluted in tissue culture medium to 1  106
CFU/ml. Bacterial numbers were determined by optical density at 600 nm and
confirmed by plating dilutions on agar plates.
Viral infection of epithelial cells. Respiratory epithelial cells were grown to
confluence and triplicate wells incubated with viruses at a multiplicity of infection
(MOI) of one virus/cell for 1 h at 37°C in 5% CO2 and washed, and medium was
replaced. At 24-h intervals, cells were detached from plates using cell dissocia-
tion solution (CDS) (Sigma), and the percentages of cells expressing viral anti-
gens were determined by fluorescence-activated cell sorting (FACS). Cells were
resuspended in 1% bovine serum albumin in PBS and incubated for 1 h at 37°C
with a 1/1,000 dilution of fluorescein isothiocyanate (FITC)-labeled goat anti-
RSV (Chemicon International, Temicula, CA) or anti-HPIV-3 antibody (Ab)
(Chemicon) or a 1/4,000 dilution of pooled mouse monoclonal antibodies (MAb)
(immunoglobulin G1 [IgG1]) raised against the influenza virus nucleoprotein
(41), followed by a 1/500 dilution of FITC-labeled goat antimouse secondary Ab
(BD Biosciences), and analyzed on a FACSCalibur instrument using CellQuest
software (BD Biosciences).
Bacterial adhesion. Epithelial cells, approximately 5  105 cells, were seeded
in 24-well plates (Costar, Corning, Inc., Corning, NY) and triplicate wells inoc-
ulated with viruses as described above. At 24-h intervals after viral infection, cells
were washed and treated with CDS, and numbers of cells per well were deter-
mined in parallel wells using a hemocytometer. Cell monolayers were incubated
with bacteria for 1 h at 37°C, washed to remove loosely adherent bacteria, and
detached from plates by incubation with 1 trypsin–EDTA (Mediatech, Inc.,
Herndon, VA), and serial dilutions were plated for quantitative cultures. For
each assay, numbers of adherent bacteria were normalized to numbers of epi-
thelial cells.
FACS analysis was used to determine bacterial binding to live and dead cells
following viral infection. NTHi bacteria were labeled by incubation with FITC (1
mg/ml) (Sigma) in carbonate buffer containing 0.1 M NaCl, 0.09 M Na2CO3, and
0.015 M NaHCO3, pH 9.2, for 30 min. Bacteria were then washed twice with PBS
and resuspended in cell culture medium. FITC-labeled NTHi bacteria were then
incubated with uninfected or RSV-infected A549 cells as described above,
washed thrice with PBS, and detached using CDS. Cells (106) were resuspended
in PBS containing 2 g/ml of propidium iodide (PI) (Amersham Biosciences,
Piscataway, NJ). Cells were analyzed on a FACSCalibur instrument using
CellQuest software. Single-color controls containing only FITC-labeled bacteria
or PI-stained cells were analyzed, and then the percentage of FITC-labeled
NTHi bacteria binding to live (PI) or dead (PI) cells was quantified. A total
of 10,000 events were acquired using forward and side scatter and gated to
exclude cell debris.
Cell surface receptor expression. Epithelial cells were inoculated with viruses
and, at 24-h intervals, detached with CDS, and 106 cells resuspended in 1 ml of
1% bovine serum albumin in PBS. Cells were then incubated for 1 h at 25°C with
a 1/1,000 dilution of mouse anti-human ICAM-1 (CD54/ICAM-1) (IgG1; BD
Biosciences), anti-human CEACAM1 (IgG1; Calbiochem, La Jolla, CA, or
Genovac GmbH, Freiberg, Germany), anti-human PAF-r MAb (Cayman Chem-
ical, Ann Arbor, MI), or purified mouse IgG1 Ab (an isotype control; BD
Biosciences), followed by incubation with a 1/500 dilution of FITC-labeled goat
antimouse Ab (BD Biosciences) for 30 min at 4°C prior to analysis. The mean
fluorescence intensity of cells was compared to that of uninfected cells after
subtracting background produced by the isotype control Ab.
Mucin PCR. A549 and SAE cells were infected with RSV as described above.
At 24-h intervals, total RNA was extracted using Trizol (Invitrogen), according
to the manufacturer’s instructions, and muc1 and muc5AC (which are expressed
by respiratory epithelial cells) mRNA expression was evaluated by reverse tran-
scription-PCR. RNA was treated with DNase (Promega), and 4 g of total RNA
was reverse transcribed using 200 U of Superscript II reverse transcriptase
(Invitrogen) at 42°C for 55 min. cDNA (2 l) was amplified by using Taq DNA
polymerase (Promega) and the following amplification primers: muc1 forward
(5-GCACTTCTCCCCAGTTGTCTACTG-3) and reverse (5-ATGGCCAGC
GCAACCACCAGAACACAG-3); muc5AC forward (5-TACAACAACATCA
TCACGAGTGCG-3) and reverse (5-TAGGGTGCTAGGAGCTGTCACAG-
3) (39). Amplification products were separated on 1.5% agarose gels and
stained, and intensities of bands were normalized to that of -actin amplified in
parallel (38).
Western blot analysis. Epithelial cells were infected as described above. At
24-h intervals, 107 cells were suspended in 1 ml of 300 mM NaCl, 50 mM
Tris-HCl, pH 7.6, 0.5% Triton X-100, and then centrifuged at 10,000  g for 15
min at 4°C. The protein concentration of supernatants was determined by Brad-
ford assay (Bio-Rad, Hercules, CA). Proteins (30 g) were separated on a 7.5%
sodium dodecyl sulfate-polyacrylamide gel, electroblotted onto Protran mem-
branes (Schleicher & Schuell, Keene, NH) and incubated with mouse anti-
human ICAM-1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), mouse anti-
human CEACAM1 MAb (Calbiochem), rabbit anti-human PAF-r Ab (Cayman
Chemical) at a 1:1,000 dilution, or mouse anti-human -actin Ab (Sigma) at a
1:5,000 dilution for 1 h at 37°C. Bound Ab was detected using peroxidase-
conjugated goat anti-mouse or goat anti-rabbit Ab (1/4,000 dilution) and chemi-
luminescent substrate (ECL Western blotting analysis system; Amersham Bio-
sciences, Piscataway, NJ). Differences in protein expression were quantified by
integrated density analysis (Eagle Sight software; Stratagene) and normalized to
-actin expression on the same membrane.
Inhibition of bacterial adhesion. The ability of NTHi to adhere to RSV-
infected A549 cells was assessed after incubation of A549 cells with increasing
concentrations (5 to 25 g/ml) of purified mouse anti-human CD54/ICAM-1
monoclonal antibody (BD Biosciences), purified mouse anti-human PAF-r
monoclonal antibody (Cayman Chemical), or mouse anti-human LFA-3/CD58
antibody (BD-Biosciences) for 1 h at 37°C.
Statistical analysis. Data are expressed as means  standard errors. Compar-
ison between groups was performed using the Mann-Whitney U test, and other
data were analyzed by Student’s t test, with P values of 	0.05 considered signif-
icant.
RESULTS
Viral infection of respiratory epithelial cells. The proportion
of epithelial cells expressing viral antigens was analyzed to
determine the relative efficiency of viral infection. The per-
centage of cells expressing viral antigens increased with time
after inoculation and was generally comparable among the
different cell types and viruses (Table 1).
The viability of epithelial cells was determined using trypan
blue exclusion. After 48 h of infection with all viruses, at least
93% of all cell types remained viable. After 72 h, 87 to 90% of
cells infected with HPIV-3 or influenza virus and 80 to 85% of
cells infected with RSV remained viable.
Antecedent respiratory viral infection increased NTHi and
S. pneumoniae adhesion to respiratory epithelial cells. The
proportion of the inoculum of NTHi strain 778 adhering to
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A549 cells was inoculum dependent: 15% at an MOI of 2
bacteria per cell, 11% at an MOI of 20, and 10% at an MOI of
200. For S. pneumoniae 357, the proportion of adherent bac-
teria was 6% at an MOI of 2, 3.5% at an MOI of 20, and 2.2%
at an MOI of 200 (data not shown). An MOI of 2 was used for
subsequent studies.
Adhesion of both NTHi and S. pneumoniae to respiratory
epithelial cells was significantly increased following infection
with RSV (Fig. 1). Adherence of NTHi strains 781, 786, 801,
and Rd to A549 cells also increased by 4.7-, 3.5-, 3-, and 6-fold,
respectively, after 72 h of RSV infection. In -contrast, adhesion
of the encapsulated strain Eagan to RSV-infected A549 cells
increased by only 1.4-fold (data not shown).
A549 cells were then infected with HPIV-3 and influenza
virus to determine if the augmentation of bacterial adhesion
observed with RSV was a general feature of respiratory viral
infections. Infection with each of these viruses increased num-
bers of adherent NTHi and pneumococci (Fig. 2). NTHi and
pneumococcal adherence to HPIV-3-infected A549 and
NHBE cells increased progressively over 72 h. While NTHi
FIG. 1. Adhesion of NTHi and S. pneumoniae to respiratory epithelial cells is increased following infection with RSV. Respiratory epithelial
cells were infected with RSV and at 24-h intervals incubated with NTHi-778 or S. pneumoniae. Adhesion is expressed as a percentage of inoculum.
Antecedent infection of all cells with RSV resulted in a statistically significant increase in bacterial adhesion (, P 	 0.005; , P 	 0.05) compared
to control cells not infected by RSV. (A) Adhesion of NTHi to respiratory epithelial cells. (B) Adhesion of pneumococci to respiratory epithelial
cells. Data represent the mean  standard error of the mean for six separate experiments.
TABLE 1. Percentages of cells expressing viral antigens following viral infectiona
Time (h)
% of cells expressing antigen after infection with:
RSV HPIV Influenza virus
A549 BEAS-2B SAEC NHBE A549 NHBE A549 NHBE
24 3  0.7 4  0.8 5  0.8 10  1.2 2  0.8 7  0.7 2  0.3 6  2.2
48 43  6.3 45  2.6 15  1.7 52  3.5 33  9.8 35  3.8 28  3.6 32  4.1
72 69  12 68  3.2 55  3.4 71  6.7 66  8.5 65  4.8 61  8.1 59  7.5
a A549, immortalized human type II alveolar cells; BEAS-2B, immortalized human bronchial epithelial cells; SAE, primary small airway epithelial cells; NHBE,
primary human bronchial epithelial cells.
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adherence to influenza virus-infected A549 and NHBE cells
and pneumococcal adherence to influenza virus-infected
NHBE cells similarly increased with time, pneumococcal ad-
herence to influenza virus-infected A549 cells was maximal at
24 h after viral infection and fell to baseline levels of adherence
at 72 h (Fig. 2).
FACS analysis demonstrated that in the absence of RSV
infection, a mean of 95% of NTHi bacteria bound to the 95%
of the cells that were viable. At 48 h after RSV infection, a
mean of 89% of NTHi bacteria bound to the 91% of the cells
that remained viable. Thus, NTHi bound live and dead cells
approximately equally for both uninfected cells and cells in-
fected with RSV (data not shown).
RSV infection increased expression of eukaryotic receptors
for respiratory bacteria in a cell type-dependent fashion. We
then determined if infection with RSV, HPIV-3, or influenza
virus altered the expression of known epithelial receptors for
these bacteria and augmented bacterial adhesion to epithelial
cells. By FACS analysis, expression of ICAM-1 was only
slightly greater than that of control uninfected A549 cells after
24 h of RSV infection but increased 30-fold  2-fold at 48 h (P
	 0.001) and 50-fold  3-fold (P 
 0.008) after 72 h (Fig. 3).
CEACAM1 expression also did not differ from baseline ex-
pression at 24 h but increased 8-fold  1-fold after 48 h (P 

0.006) and 9-fold  1-fold (P 
 0.008) at 72 h after RSV
infection. PAF-r expression could not be quantified by FACS
due to the low density of receptors on the cell surface. Western
blot analysis of A549 cells lysates confirmed the increased
expression of ICAM-1 and CEACAM1 and demonstrated in-
creased PAF-r expression after infection with RSV (Fig. 3).
ICAM-1 expression increased by up to 34-fold  3-fold and
CEACAM1 expression by up to 12-fold  1-fold over the 72 h
after RSV infection. PAF-r expression was unchanged at 24 h
but increased by 4-fold  1-fold at 72 h.
RSV infection also increased expression of ICAM-1 and
PAF-r by BEAS-2B cells (Fig. 3). Expression of ICAM-1 in-
creased 1.2-fold  0.2-fold at 24 h, 1.3-fold  0.2-fold at 48 h,
and 1.6-fold  0.2-fold (P 
 0.03) at 72 h. PAF-r expression
increased 1.1-fold  0.1-fold at 24 h, 1.5-fold  0.2-fold (P 

0.03) at 48 h, and 2-fold  0.3-fold (P 
 0.02) at 72 h after
RSV infection. Expression of CEACAM-1 by BEAS-2B cells,
however, was not altered after RSV infection.
RSV infection also increased the expression of ICAM-1 by
NHBE cells by 3.5-fold  0.8-fold at 48 h and 7-fold  1-fold
(P 
 0.008) at 72 h (Fig. 3) and CEACAM1 expression by
3-fold  0.5-fold (P 
 0.01) at 48 h and 4-fold  0.3-fold (P 

0.02) at 72 h. Expression of PAF-r by NHBE cells did not
increase. In contrast to other cells, RSV did not significantly
alter the expression of ICAM-1, CEACAM1, and PAF-r by
SAE cells (data not shown). Finally, RSV infection did not
FIG. 2. Adhesion of NTHI and S. pneumoniae to respiratory epithelial cells is increased following infection with HPIV-3 and influenza virus.
Respiratory epithelial cells were infected with HPIV-3 or influenza virus and at 24-h intervals incubated with NTHi-778 or S. pneumoniae.
Adhesion is expressed as a percentage of inoculum. Bacterial adhesion was significantly increased to virally infected cells compared to adhesion
to control cells not infected by viruses (, P 	 0.005; , P 	 0.01; , P 	 0.05). (A) Adhesion of NTHi to respiratory epithelial cells. (B)
Adhesion of pneumococci to respiratory epithelial cells. Data represents the means  standard errors of the means of six separate experiments.
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alter the expression of muc1 or muc5AC by A549 or SAE cells
(data not shown).
In summary, RSV increased the expression of ICAM-1,
CEACAM1, and PAF-r by A549, BEAS-2B, and NHBE cells.
The magnitude of this effect varied significantly between cell
types.
Blocking ICAM-1 and PAF-r after RSV infection prevented
adhesion of NTHi and pneumococci to A549 cells. Blocking
assays were used to determine if the increased bacterial adher-
ence of NTHi to RSV-infected cells was attributable to in-
creased receptor expression. NTHi binding was inhibited in a
dose-dependent manner when A549 cells were incubated with
increasing concentrations of anti-ICAM-1, anti-PAFr, or both
Ab but not by the control anti-LFA-3/CD58 Ab (Fig. 4). Anti-
ICAM-1 Ab inhibited adhesion by 75% (from 0.75  0.09 to
0.26  0.06 bacteria/cell) after 24 h (P 
 0.005), 65% (from
1.34  0.13 to 0.47  0.14 bacteria/cell) at 48 h (P 	 0.005),
and by 61% (from 1.56  0.11 to 0.61  0.11 bacteria/cell)
after 72 h of RSV infection (P 	 0.001). Anti-PAF-r Ab in-
hibited adhesion of NTHi by 48% (from 0.75  0.09 to 0.39 
0.09 bacteria/cell) at 24 h (P 
 0.01), 45% (from 1.34  0.13 to
0.75  0.14 bacteria/cell) at 48 h (P 
 0.002), and by 30%
(from 1.56  0.16 to 1.09  0.28 bacteria/cell) after 72 h of
RSV infection (P 
 0.01). The combination of anti-ICAM-1
and anti-PAF-r Ab inhibited NTHi adhesion by 85% (from
0.75  0.09 to 0.11  0.06 bacteria/cell) after 24 h (P 
 0.002),
80% (from 1.34  0.13 to 0.30  0.08 bacteria/cell) at 48 h (P

 0.004), and by 79% (from 1.56  0.16 to 0.33  0.13 bac-
teria/cell) after 72 h of infection (P 
 0.003). These data
suggest that the increase in NTHi adhesion to RSV-infected
cells was largely, but not completely, attributable to increased
expression of specific receptors.
Pneumococcal adhesion to A549 cells after 72 h of RSV
infection was reduced by 65% following preincubation of epi-
thelial cells with anti-PAF-r antibody (25 g/ml) but was not
significantly reduced by anti-ICAM-1 antibody (data not
shown). These data suggest that the increase in pneumococcus
adhesion to RSV-infected A549 cells was due in part to up-
regulation of PAF-r and are consistent with the observation
that NTHi but not pneumococci bind ICAM-1 (2a).
HPIV-3 infection also increased cell surface expression of
eukaryotic receptors for respiratory bacteria, but influenza
virus infection did not. The expression of ICAM-1, CEACAM1,
and PAF-r was measured after infection of A549 and NHBE
FIG. 3. ICAM-1, CEACAM1, and PAF-r expression by epithelial cells after RSV infection. (A) Cells were infected by RSV for 24, 48, or 72 h,
and receptor expression was quantified by FACS. Histograms illustrate the fluorescence intensities of control cells (not infected with virus)
compared to those of infected cells at 24, 48, and 72 h. RSV infection up-regulated A549 cell ICAM-1 and CEACAM-1 expression at 48 to 72 h,
BEAS-2B ICAM-1 and PAF-r expression at 48 to 72 h, and NHBE cell ICAM-1 and CEACAM-1 expression at 48 and 72 h. (B) Up-regulation
of receptors by RSV infection of A549 cells was confirmed by Western blot analysis. Data are representative of three independent experiments.
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cells by HPIV-3 to determine if the ability to up-regulate re-
ceptor expression is shared by other paramyxoviruses. Expres-
sion of ICAM-1 by A549 cells after infection with HPIV-3 did
not differ from that of uninfected control cells at 24 h but
increased 4-fold 1-fold at 48 h (P
 0.03) and 9-fold 1-fold
at 72 h (P 
 0.04) (Fig. 5); expression of CEACAM1 on A549
cells was only minimally increased. HPIV-3 infection did not
alter A549 cell expression of PAF-r. Western blot analysis of
HPIV-3-infected A549 cell lysates confirmed the increased
expression of ICAM-1, demonstrated an increase in
CEACAM1 expression, and showed no difference in PAF-r
expression (Fig. 5). Expression of ICAM-1 by HPIV-3-infected
NHBE cells increased by 2.5-fold at 48 h (P 
 0.01) and
4.8-fold (P 
 0.005) at 72 h and CEACAM1 expression by
2.8-fold (P 
 0.02) at 48 h and 3.8-fold (P 
 0.01) at 72 h, and
there was no change in the expression of PAF-r. In contrast to
the case with other viruses, influenza virus infection did not
alter receptor expression (data not shown).
DISCUSSION
Several clinical observations suggest that viral infection
might enhance bacterial colonization of the respiratory epithe-
lium, allowing microorganisms to overcome physical barriers
to infection and evade innate immune responses. Monso and
colleagues found that patients with an acute exacerbation of
chronic obstructive pulmonary disease (COPD) had greater
bacterial loads than those with stable pulmonary disease (25).
Viral respiratory infections were also associated with a greater
likelihood of isolation of H. influenzae and S. pneumoniae from
sputum cultures and a higher incidence of H. influenzae anti-
body seroconversion (36). In the current study, we show that
RSV, HPIV-3, or influenza virus infection of respiratory epi-
thelial cells increases adherence of NTHi and S. pneumoniae
but that the mechanisms responsible for this phenomenon dif-
FIG. 4. Blocking ICAM-1 and PAF-r reduces NTHi adhesion to
RSV-infected respiratory epithelial cells. A549 cells were infected with
RSV for 24, 48, or 72 h and then incubated with anti-LFA-3/CD58,
anti-ICAM-1, anti-PAF-r, or both anti-ICAM-1 and anti-PAFr Ab,
and numbers of NTHi bacteria adhering to cells were determined.
Shown is the inhibition observed after incubation of A549 cells with 25
g/ml of Ab. (A) Adhesion of NTHi-778 at 24 h. (B) Adhesion after
48 h. (C) Adhesion after 72 h. Treatment with both anti-ICAM-1 and
PAF-r antibodies but not control anti-LFA-3/CD58 Ab resulted in a
significant inhibition of NTHi adhesion. (, P  0.005; , P 
 0.01).
Data represent the means  standard errors for three independent
experiments.
FIG. 5. HPIV-3 infection increases ICAM-1 and CEACAM1 ex-
pression by respiratory epithelial cells. (A) Cells were infected by
HPIV-3 for 24, 48, or 72 h, and receptor expression was quantified by
FACS. Histograms illustrate the fluorescence intensities of control
cells (not infected with virus) compared to those of infected cells at 24,
48, and 72 h. HPIV-3 infection significantly increased expression of
ICAM-1 and modestly increased expression of CEACAM1 by A549
cells and significantly increased ICAM-1 and CEACAM1 expression
by NHBE cells at 48 to 72 h after infection. (B) The increased expres-
sion of receptors by A549 cells following HPIV-3 infection was con-
firmed by Western blot analysis. Data are representative of three
independent experiments.
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fer between the paramyxoviruses (RSV and HPIV-3) and in-
fluenza virus and vary according to cell type.
A549 and BEAS-2B are transformed cell lines derived from
type II alveolar and normal bronchial epithelial cells, respec-
tively. NHBE and SAE cells are primary epithelial cells ob-
tained from bronchi and the distal bronchial tree and are likely
to include a heterogeneous population of cells. Thus, none of
these cells are completely representative of an individual cell
type or respiratory epithelium as a whole. RSV and HPIV-3
up-regulated ICAM-1, CEACAM1, and PAF-r but not mucin
on the surfaces of A549, BEAS-2B, and NHBE but not SAE
cells, and much of the increased bacterial adhesion following
RSV infection could be blocked by antibodies directed against
these receptors. In contrast, influenza virus promoted bacterial
adhesion without significantly altering expression of the recep-
tors studied.
One explanation for these differences between cell types
may be that these cells do not express the same baseline or
stimulated number of surface receptors. A549 cells, for exam-
ple, had low constitutive expression of ICAM-1 and PAF-r
compared to SAE and BEAS-2B cells (data not shown). The
expression of ICAM-1 was greater in RSV-infected A549 cells
than in BEAS-2B cells, while the converse was true for expres-
sion of PAF-r. These data indicate that increased bacterial
adhesion to SAE cells is mediated by receptors not tested in
the present study. Although bacterial adhesion to each cell
type is augmented by viral infection, alteration of receptor
expression may be only one means by which bacterial adhesion
is increased. Mechanisms independent of the expression of
conventional receptors for bacteria, such as binding to viral
proteins, could also be responsible for enhanced adhesion (12).
Although these studies have focused on lower respiratory tract
infections, RSV, HPIV-3, and influenza virus have also been
implicated in other secondary bacterial infections, including
otitis media and sinusitis. It is possible that the increased
adhesion of bacteria to virus-infected cells and the regulation
of eukaryotic receptors for bacteria by viruses may also be
relevant to these infections.
Immunofluorescence microscopy demonstrated that bacte-
ria binding to RSV-infected A549 cells adhere not only to
those cells expressing viral antigens but also to uninfected
epithelial cells (data not shown). These data suggest that the
ability to augment bacterial adhesion may result from a factor
secreted by infected cells that exerts a paracrine effect on
adjacent epithelium. Cytokines or other inflammatory mole-
cules are good candidates for such a mediator. Increased
ICAM-1, PAF-r, and CEACAM1 expression by epithelial cells
is mediated by interleukin 1 alpha (IL-1), tumor necrosis
factor alpha, and interleukin 6, which have been reported to be
secreted by RSV-infected epithelial cells (7–9, 21, 30). Fur-
thermore, RSV infection of primary small airway, bronchial,
and bronchiolar epithelial cells and A549 cells results in cell-
specific inflammatory responses (28). Another explanation for
variations in receptor expression is that the effects of inflam-
matory mediators, rather than their absolute concentrations of
factors, may differ between cell types.
In this study, the greatest increase in both bacterial adhesion
and receptor expression occurred following RSV infection. If
inflammatory mediators are responsible for increased expres-
sion of ICAM-1, CEACAM1, and PAF-r, it is possible that the
more-pronounced effect of RSV is related to differences in the
character or magnitude of the inflammatory responses trig-
gered by different viruses (2, 22, 27, 30). Recent studies suggest
that the proinflammatory cytokine release triggered by influ-
enza virus infection of bronchiolar epithelial cells is limited by
the ability of the virus to induce host cell apoptosis (5). Finally,
although differences in the degree of inflammation elicited by
RSV, HPIV-3, and influenza virus infection described by other
investigators appear to correspond to receptor expression,
other mechanisms may also influence this process. HPIV-3, for
example, induces ICAM-1 expression in a cytokine-indepen-
dent manner (10).
The difference in the magnitude and kinetics of S. pneu-
moniae adhesion to virus-infected A549 cells implies that S.
pneumoniae and influenza virus interact in a unique manner.
Paramyxoviruses enhanced bacterial attachment progressively
over 72 h. Increased adhesion of S. pneumoniae to influenza
virus-infected cells, in contrast, peaked at 24 h and then grad-
ually declined to a level comparable to that of adhesion to
uninfected control cells. Previous studies have also demon-
strated an increase in numbers of pneumococci adhering to
A549 cells as early as 30 min after infection with influenza virus
but did not study later time points (23). Consistent with our
observation that influenza virus does not up-regulate PAF-r,
mice treated with a PAF-r antagonist had no reduction in the
severity of secondary pneumococcal pneumonia after influenza
virus infection (24). Our data support an alternative mecha-
nism of increased bacterial adherence, such as the model put
forward by McCullers and colleagues, where influenza virus
neuraminidase cleaves sialic acid on eukaryotic cells, allowing
pneumococci to adhere to epithelial cells in greater numbers
(23). Interestingly, HPIV-3 also possesses a hemagglutinin
neuraminidase, and the role of this enzyme in promoting pneu-
mococcal adherence cannot be excluded (1).
The ability of antecedent viral infections to trigger secondary
bacterial infections is also likely to depend on host factors. It
might be expected that infection by the most highly prevalent
of these respiratory viruses, RSV, would lead to a dispropor-
tionately increased frequency of exacerbations of COPD. Al-
though RSV has been implicated in 29 to 51% of exacerbations
of COPD in some studies, this is not consistently the case (13,
34, 40). Differences in exposure to viruses, rates of influenza
virus vaccination, and detection methods may account for
some of the discrepancy between these studies. Repeated in-
fections with RSV occur throughout an individual’s life, usually
producing partial immunity and more minor illness with sub-
sequent infections (14). In contrast, antigenic drift of influenza
viruses may result in the rapid loss of protective immunity,
irrespective of age and previous infection.
Our data suggest that in addition to other effects, respiratory
viral infection may predispose to bacterial secondary infections
by promoting bacterial adhesion to the respiratory epithelium.
Perhaps most importantly, these studies demonstrate marked
differences in the responses of different respiratory epithelial
cells to infection by the same virus and in the effects of infec-
tion by different viruses on the same cell type. These findings
emphasize the importance of considering these experimental
factors in future work and the need to translate important
findings from in vitro studies to an appropriate in vivo model
of infection (3, 11). Further examination of the interactions
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between respiratory bacterial and viral pathogens will clarify
the mechanisms responsible for secondary bacterial infections,
and strategies to circumvent these processes may help reduce
these complications.
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SPOTLIGHT
Articles of Significant Interest Selected from This Issue by the Editors
Chromatin Remodeling Is an Early Event in HSV-1 Reactivation
Herpes simplex virus type 1 (HSV-1) latency in sensory neurons is characterized by the expression of the latency-
associated transcript (LAT) and the suppression of lytic gene expression. Amelio et al. (p. 2063–2068) show that histones
associated with the LAT promoter and enhancer are rapidly deacetylated during explant-induced reactivation. This
deacetylation precedes a decrease in LAT abundance and is followed by an acetylation of the promoter of the lytic
transactivator ICP0. These findings suggest that the initial reactivation stimulus may direct epigenetic changes in
chromatin at the LAT/ICP0 regulatory region and that LAT expression must be silenced for reactivation to occur.
Reovirus Induces and Benefits from a Cellular Integrated Stress Response
Most strains of reovirus induce translational shutoff, in part by activating stress pathways that lead to phosphorylation of
the essential eukaryotic translation initiation factor eIF2a. Although this cellular response thwarts replication of most
viruses, Smith et al. (p. 2019–2033) found that reovirus replicates most efficiently under conditions in which eIF2a can
be phosphorylated and inhibited. This work has implications for understanding the competition between cellular and viral
molecules for limited cellular components and suggests that reovirus has evolved to benefit from the integrated stress
response induced as a consequence of infection.
LEDGF/p75 Is Important for HIV Replication
The transcriptional coactivator lens epithelium-derived growth factor (LEDGF/p75) interacts with human immunode-
ficiency virus type 1 (HIV-1) integrase. Vandekerckhove et al. (p. 1886–1896) show, using RNAi-based experiments, that
HIV-1 replication is reduced after transient and stable knockdown of LEDGF/p75. Quantitative PCR pinpoints the
replication block to the integration step. This work validates LEDGF/p75 as an important cellular cofactor for HIV
integration and suggests a potential new target for antiviral drug development.
Lung Dendritic Cell Function Suppressed by Adenovirus
Mechanisms by which adenovirus (Ad) infection induces pulmonary disease are unknown. Ad is an adjuvant for bone
marrow and monocyte-derived dendritic cells (DCs); however, the effect of Ad infection on primary lung DCs, the key
stimulator of pulmonary immunity, had not been reported. Thiele et al. (p. 1826–1836) demonstrate that Ad suppresses
the capacity of lung DCs to stimulate T cells. These findings suggest that Ad induces pulmonary immune suppression,
which has implications for an understanding of postviral pneumonias and the use of Ad in gene delivery.
Novel Imaging Technique Analyzing Influenza Virus Membrane Fusion
As new influenza viruses have the potential to cause worldwide pandemics, there is a pressing need for methodologies
to quickly determine viral infectivity by using human cells. Sakai et al. (p. 2013–2018) have developed a new microscopic
technique that allows for fast and sensitive detection of influenza virus membrane fusion, a crucial event in influenza virus
replication. This work establishes a methodology with the potential to rapidly survey virulent influenza viruses.
HIV env Evolves toward Ancestral States upon Transmission to a New Host
Analyses of human immunodeficiency virus (HIV) evolution have generally assumed that genetic divergence accumu-
lated within hosts is maintained through transmission events. However, Herbeck et al. (p. 1637–1644) show that this
continuous divergence is partially reset following transmission. They demonstrate that convergent evolutionary changes
toward a more ancestral state occur in the envelope gene within the first year of infection. These findings provide impetus
for the development of vaccine immunogens that favor inclusion of viral sequences sampled from early in infection and
that embody ancestral or consensus features of viruses circulating in a given population.
1617
Structure-Function Analysis of the Epitope for 4E10, a Broadly Neutralizing Human Immunodeficiency Virus
Type 1 Antibody
Human monoclonal antibody 4E10 binds to a highly conserved epitope in the membrane-proximal external region
(MPER) of human immunodeficiency virus type 1 (HIV-1) gp41. The crystal structure of this complex is characterized
by a helical epitope and suggests that stabilized MPER peptides might be candidates for a synthetic HIV-1 vaccine.
Brunel et. al. (p. 1680–1687) report a detailed mapping of the 4E10 epitope by the use of synthetic peptides. This
structural and functional analysis guided the design of conformationally constrained peptides that are helical in solution.
These peptide mimics have low nanomolar affinity for 4E10 and are promising leads for a synthetic HIV-1 vaccine.
Respiratory Viruses Promote Bacterial Adhesion to Epithelial Cells
Respiratory viruses predispose humans to secondary bacterial infections, but mechanisms responsible for this phenom-
enon are not well understood. Avadhanula et al. (p. 1629–1636) demonstrate that antecedent infection of respiratory
epithelial cells by common viral pathogens increases the number of nontypeable Haemophilus influenzae and Strepto-
coccus pneumoniae adhering to cells. The mechanisms and degree to which individual viruses promote bacterial colo-
nization, however, differ and are cell type-dependent. This work underscores the need to consider this variation when
extrapolating results of in vitro assays to human disease.
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